Noah Berkowitz - 18 Mar 2025 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Medical Officer
Signature
/s/ Christina Bailey, as attorney-in-fact for Noah Berkowitz
Issuer symbol
ARVN
Transactions as of
18 Mar 2025
Net transactions value
-$74,372
Form type
4
Filing time
19 Mar 2025, 08:06:56 UTC
Previous filing
18 Feb 2025
Next filing
13 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Sale $74,372 -8,658 -7.3% $8.59 110,023 18 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024.